Literature DB >> 10899874

Failure To detect muramic acid in normal rat tissues but detection in cerebrospinal fluids from patients with Pneumococcal meningitis.

M P Kozar1, M T Krahmer, A Fox, B M Gray.   

Abstract

Muramic acid serves as a marker for the presence of bacterial cell wall debris in mammalian tissues. There have been a number of controversial and sometimes conflicting results on assessing the levels of muramic acid in health and disease. The present report is the first to use the state-of-the art technique, gas chromatography-tandem mass spectrometry, to identify and quantify the levels of muramic acid in tissues. Muramic acid was not found in normal rat brain or spleen. However, when tissues were spiked with muramic acid, it was readily identified. The detection limit was <1 ng of muramic acid/100 mg (wet weight) of tissue. The levels of muramic acid reported in diseased human spleen and spleen of arthritic rats, previously injected with bacterial cell walls, were 100- to 1,000-fold higher. In the present study, muramic acid was also readily detected in the cerebrospinal fluid of patients with pneumococcal meningitis (6.8 to 3,900 ng of muramic acid/ml of cerebrospinal fluid). In summary, there can be an enormous difference in the levels of muramic acid found in different mammalian tissues and body fluids in health and disease. This report could have great impact in future studies assessing the role of bacterial cell wall remnants in the pathogenesis of certain human inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10899874      PMCID: PMC98412          DOI: 10.1128/IAI.68.8.4688-4698.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Extraction of sleep-promoting factor S from cerebrospinal fluid and from brains of sleep-deprived animals.

Authors:  J R Pappenheimer; G Koski; V Fencl; M L Karnovsky; J Krueger
Journal:  J Neurophysiol       Date:  1975-11       Impact factor: 2.714

2.  Clinical outcome in pneumococcal meningitis correlates with CSF lipoteichoic acid concentrations.

Authors:  O Schneider; U Michel; G Zysk; O Dubuis; R Nau
Journal:  Neurology       Date:  1999-10-22       Impact factor: 9.910

3.  Reactive arthritis associated with Campylobacter jejuni enteritis.

Authors:  J H Berden; H L Muytjens; L B van de Putte
Journal:  Br Med J       Date:  1979-02-10

Review 4.  The molecular basis of pneumococcal infection: a hypothesis.

Authors:  D Cundell; H R Masure; E I Tuomanen
Journal:  Clin Infect Dis       Date:  1995-12       Impact factor: 9.079

5.  An "experimental" epidemic of Reiter's syndrome.

Authors:  H R Noer
Journal:  JAMA       Date:  1966-11-14       Impact factor: 56.272

6.  Degradation of 14C-labeled streptococcal cell walls by egg white lysozyme and lysosomal enzymes.

Authors:  H A Gallis; S E Miller; R W Wheat
Journal:  Infect Immun       Date:  1976-05       Impact factor: 3.441

7.  Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model.

Authors:  R D Berg; A W Garlington
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

8.  An "experimental" epidemic of Reiter's syndrome revisited. Follow-up evidence on genetic and environmental factors.

Authors:  A Calin; J F Fries
Journal:  Ann Intern Med       Date:  1976-05       Impact factor: 25.391

9.  The infectious etiology of rheumatoid arthritis. New considerations.

Authors:  J C Bennett
Journal:  Arthritis Rheum       Date:  1978-06

10.  Arthritis in rats after systemic injection of streptococcal cells or cell walls.

Authors:  W J Cromartie; J G Craddock; J H Schwab; S K Anderle; C H Yang
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

View more
  8 in total

1.  Characterization of a monoclonal antibody that binds to an epitope on soluble bacterial peptidoglycan fragments.

Authors:  G J Merkel; B A Scofield
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

Review 2.  Mass spectrometry for species or strain identification after culture or without culture: Past, present, and future.

Authors:  Alvin Fox
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

3.  Muramic acid is not generally present in the human spleen as determined by gas chromatography-tandem mass spectrometry.

Authors:  Michael P Kozar; Jon D Laman; Alvin Fox
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

4.  Enzyme degradation and proinflammatory activity in arthritogenic and nonarthritogenic Eubacterium aerofaciens cell walls.

Authors:  X Zhang; M Rimpiläinen; E Simelyte; P Toivanen
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

5.  Stereo-isomer specific induction of renal cell apoptosis by synthetic muramyl dipeptide (N-acetylmuramyl-L-alanyl-D-isoglutamine).

Authors:  Marlyn P Langford; Dequan Chen; Tomas C Welbourne; Thomas B Redens; James P Ganley
Journal:  Mol Cell Biochem       Date:  2002-07       Impact factor: 3.396

Review 6.  Regulation of Immune Homeostasis via Muramyl Peptides-Low Molecular Weight Bioregulators of Bacterial Origin.

Authors:  Svetlana V Guryanova
Journal:  Microorganisms       Date:  2022-07-28

7.  4-Hydroxyphenyllactic Acid in Cerebrospinal Fluid as a Possible Marker of Post-Neurosurgical Meningitis: Retrospective Study.

Authors:  Alisa K Pautova; Anastasiia Yu Meglei; Ekaterina A Chernevskaya; Irina A Alexandrova; Natalia V Beloborodova
Journal:  J Pers Med       Date:  2022-03-04

8.  A muramidase from Acremonium alcalophilum hydrolyse peptidoglycan found in the gastrointestinal tract of broiler chickens.

Authors:  Carsten Østergaard Frederiksen; Marianne Thorup Cohn; Lars Kobberøe Skov; Esben Gjerløff Wedebye Schmidt; Kirk Matthew Schnorr; Steen Buskov; Miika Leppänen; Ilari Maasilta; Estefania Perez-Calvo; Rual Lopez-Ulibarri; Mikkel Klausen
Journal:  J Ind Microbiol Biotechnol       Date:  2021-04-30       Impact factor: 4.258

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.